Orion Portfolio Solutions’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-35,565
Closed -$5.01M – 571
2020
Q4
$5.01M Sell
35,565
-3,450
-9% -$442K 0.23% 70
2020
Q3
$4.35M Sell
39,015
-3,374
-8% -$378K 0.23% 69
2020
Q2
$4.75M Sell
42,389
-2,715
-6% -$267K 0.26% 64
2020
Q1
$3.49M Sell
45,104
-3,883
-8% -$344K 0.24% 63
2019
Q4
$4.66M Buy
+48,987
New +$4.24M 0.37% 55

Other funds holding XBI

Orion Portfolio Solutions's XBI Position: Q1 2021 in Review

Orion Portfolio Solutions sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2021, closing a stake of 35,565 shares — an estimated $5.01M sold.

Orion Portfolio Solutions first reported a position in XBI in Q4 2019 and held it in 5 quarters. The position peaked at $5.01M in Q4 2020. 643 funds tracked by Wall St. Rank hold XBI as of Q1 2021.

  • Orion Portfolio Solutions reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2021 after selling out during the quarter.
  • Orion Portfolio Solutions sold 35,565 State Street SPDR S&P Biotech ETF shares in Q1 2021, an estimated $5.01M.
  • Orion Portfolio Solutions first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 5 quarters.
  • Orion Portfolio Solutions's State Street SPDR S&P Biotech ETF position peaked at $5.01M in Q4 2020.
  • 643 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2021.

Based on Orion Portfolio Solutions's 13F filing for Q1 2021, filed 17 May 2021.